Concepedia

Y Li

YL

Statistics

Publications

6

Citations

575

H-Index

6

Active since

1996

Affiliations

Dana-Farber Cancer Institute(Current)

Y Li is an author at Dana-Farber Cancer Institute specializing in oncology, life sciences, and pharmacology.

Publications per year

1996–2001

6

Publications

6

Cortactin potentiates bone metastasis of breast cancer cells.

Y Li, M. Mehrdad Tondravi, Jun Liu et al. · PubMed · 2001 · 198 citations

Medicine, Molecular Biology, Oncology +17

MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation.

K. KOYA, Y Li, Handong Wang et al. · PubMed · 1996 · 181 citations

Medicine, Oncology, Pharmacology +6

Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077.

Josephine S. Modica-Napolitano, K. KOYA, Ellen Weisberg et al. · PubMed · 1996 · 123 citations

Life Sciences, Oncology, Pharmacology +17

In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function.

Ellen Weisberg, K. KOYA, Josephine S. Modica-Napolitano et al. · PubMed · 1996 · 48 citations

Life Sciences, Pharmacology, Toxicology +17

Cell surface expression of urokinase receptor in normal mammary epithelial cells and breast cancer cell lines.

Y Li, Nancy B. Wood, David Yellowlees et al. · PubMed · 1999 · 13 citations

Life Sciences, Cell Biology, Oncology +16

1–5 of 6